Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical standards for antimicrobial stewardship in TB care.

IJTLD open·2025
Same author

An assessment of video-observed treatment as an adherence support tool for patients with drug-resistant TB.

IJTLD open·2025
Same author

TB elimination in Southern Africa: overview and critical reflection.

IJTLD open·2025
Same author

Clinical best practices for caring for people with expanded resistance to newer TB drugs.

IJTLD open·2025
Same author

Children and providers' perspectives on once-weekly rifapentine and isoniazid TB preventive therapy.

IJTLD open·2025
Same author

TB preventive therapy preferences among children and adolescents.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023

Related Experiment Videos

Double trouble: enhancing integrated services for TB and diabetes.

K Jayendran1, M N Williams2, N Shongwe3

  • 1ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, USA;, Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
|June 2, 2026
PubMed
Summary

Healthcare providers in Eswatini see the need for better integrated services for tuberculosis (TB) and diabetes mellitus (DM). Improving patient education materials and training are key to better TB-DM care.

Related Experiment Videos

Area of Science:

  • Public Health
  • Infectious Diseases
  • Endocrinology

Background:

  • Tuberculosis (TB) remains a significant global health issue, disproportionately affecting low- and middle-income countries.
  • Diabetes Mellitus (DM) exacerbates the risk of developing active TB, highlighting the need for integrated care strategies.
  • The World Health Organization (WHO) advocates for the integration of DM screening and management within TB clinics to enhance patient outcomes.

Purpose of the Study:

  • To explore healthcare providers' perspectives on integrating TB-DM services in Eswatini.
  • To assess the potential utility of a TB-DM educational pamphlet for patient care.
  • To identify barriers and facilitators for effective TB-DM service integration.

Main Methods:

  • Development of a TB-DM educational pamphlet in collaboration with stakeholders.
  • Conducting in-depth interviews with 17 healthcare providers (HCPs) from urban and rural TB facilities in Manzini, Eswatini.
  • Gathering HCPs' insights on integrating TB-DM services and the pamphlet's role.

Main Results:

  • Most HCPs felt confident in diagnosing DM among TB patients.
  • Key recommendations for improving TB-DM services included enhancing patient education materials, standardizing diagnostic tools, increasing training and mentorship, and improving access to pharmacological information.
  • HCPs believed the pamphlet could improve patient and family education and promote adherence to lifestyle changes, with suggestions for simplifying dietary and exercise advice for the local context.

Conclusions:

  • Integrated TB-DM services require strengthened diagnostic procedures and expanded training for healthcare providers.
  • Enhanced patient education and increased support from nurse mentors are crucial for improving health outcomes in Eswatini.
  • Tailoring educational materials to the local context is essential for effective patient engagement and adherence.